Completed
The ongoing COVID-19 pandemic response has demonstrated how innovative global public-private partnerships and coordination mechanisms can lead to rapid successes in viral vaccine research, manufacturing, and risk pooling. Yet, it has also exposed continued governance barriers for effective viral pandemic preparedness and response. At the request of the U.S. Department of Health and Human Services, the National Academies have convened a committee to analyze the current influenza global governance landscape and relevancy of COVID-19 innovations, and to provide actionable recommendations for strengthening global collaborations, regulations, and financing structures around influenza vaccination.
Featured publication
Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative
Consensus Study Report
·2022
The COVID-19 pandemic has laid bare the fragility of the global system of preparedness and response to pandemics and the fragmentation of our research and development ecosystem. The pandemic has provided a disruptive moment to advance new norms and frameworks for influenza. It also has demonstrated...
View details